Prelude Capital Management, LLC Gsk PLC Call Options Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $3.05 Million - $3.61 Million	-75,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $2.94 Million - $3.27 Million	75,700 New	75,700 $2.89 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $573,364 - $650,922	-15,700 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $20,562 - $24,006	600 Added 3.97%	15,700 $560,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $3,407 - $3,994	-100 Reduced 0.66%	15,100 $556,000
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $579,272 - $653,448	15,200 New	15,200 $572,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.